Novartis'' Scemblix for blood cancer subtype gets EMA panel nod
A committee of the European Medicines Agency (EMA) recommended the approval of Novartis'' (NVS) Scemblix to treat adult patients with Philadelphia chromosome‑positive chronic…
Novartis'' Scemblix for blood cancer subtype gets EMA panel nod
A committee of the European Medicines Agency (EMA) recommended the approval of Novartis'' (NVS) Scemblix to treat adult patients with Philadelphia chromosome‑positive chronic…